Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefan J Schunk

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Journal of Clinical Medicine|July 12, 2025
Cardiovascular Risk and Its Presentation in Chronic Kidney DiseaseStefan J Schunk, Paul Zimmermann
Kidney International|August 21, 2022
Klotho in diabetic kidney disease: more than dust in the WntThimoteus Speer, Stefan J Schunk
Herz|December 30, 2020
Heart and kidney disease: a cardiovascular high-risk constellationStefan J Schunk, Thimoteus Speer, Danilo Fliser
European Heart Journal|March 27, 2018
Potassium: an ion with dangerous airs and gracesThimoteus Speer, Stefan J Schunk, Stephen Zewinger
Herz|February 28, 2024
Increased cardiovascular risk in patients with chronic kidney diseaseSonja Vondenhoff, Stefan J Schunk, Heidi Noels
Nature Reviews. Nephrology|September 29, 2020
WNT-β-catenin signalling - a versatile player in kidney injury and repairStefan J Schunk, Jürgen Floege, Danilo Fliser, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 7, 2020
Dickkopf 3-a novel biomarker of the 'kidney injury continuum'Stefan J Schunk, Thimoteus Speer, Ioannis Petrakis, et al.
Journal of the Neurological Sciences|May 20, 2024
Apheresis treatment in autoimmune neurological diseases: Predictors of good clinical outcome and success of follow-up therapy with B-cell depletionMathias Fousse, Klaus Fassbender, Stefan J Schunk, et al.
Life (Basel, Switzerland)|July 29, 2025
Cardiovascular Remodeling and Potential Controversies in Master Endurance Athletes-A Narrative ReviewOthmar Moser, Stefan J Schunk, Volker Schöffl, et al.
Nature Reviews. Nephrology|September 6, 2022
Targeting innate immunity-driven inflammation in CKD and cardiovascular diseaseThimoteus Speer, Stefanie Dimmeler, Stefan J Schunk, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Journal of Clinical Medicine|July 12, 2025
Cardiovascular Risk and Its Presentation in Chronic Kidney DiseaseStefan J Schunk, Paul Zimmermann
Kidney International|August 21, 2022
Klotho in diabetic kidney disease: more than dust in the WntThimoteus Speer, Stefan J Schunk
Herz|December 30, 2020
Heart and kidney disease: a cardiovascular high-risk constellationStefan J Schunk, Thimoteus Speer, Danilo Fliser
European Heart Journal|March 27, 2018
Potassium: an ion with dangerous airs and gracesThimoteus Speer, Stefan J Schunk, Stephen Zewinger
Herz|February 28, 2024
Increased cardiovascular risk in patients with chronic kidney diseaseSonja Vondenhoff, Stefan J Schunk, Heidi Noels
Nature Reviews. Nephrology|September 29, 2020
WNT-β-catenin signalling - a versatile player in kidney injury and repairStefan J Schunk, Jürgen Floege, Danilo Fliser, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 7, 2020
Dickkopf 3-a novel biomarker of the 'kidney injury continuum'Stefan J Schunk, Thimoteus Speer, Ioannis Petrakis, et al.
Journal of the Neurological Sciences|May 20, 2024
Apheresis treatment in autoimmune neurological diseases: Predictors of good clinical outcome and success of follow-up therapy with B-cell depletionMathias Fousse, Klaus Fassbender, Stefan J Schunk, et al.
Life (Basel, Switzerland)|July 29, 2025
Cardiovascular Remodeling and Potential Controversies in Master Endurance Athletes-A Narrative ReviewOthmar Moser, Stefan J Schunk, Volker Schöffl, et al.
Nature Reviews. Nephrology|September 6, 2022
Targeting innate immunity-driven inflammation in CKD and cardiovascular diseaseThimoteus Speer, Stefanie Dimmeler, Stefan J Schunk, et al.
Pageof 3